Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did VolitionRX Beat Earnings?

VolitionRX (VNRX) reported Q2 '26 revenue of $400,000, down 2.0% year-over-year.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — VolitionRX’s job postings, web traffic, and employee business outlook. See the full VNRX stock analysis or the earnings calendar for upcoming reports.

VolitionRX Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue470,000190,000250,000410,000630,000450,000990,000400,000
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%74.2%100.0%
Operating margin-1,236.8%-3,016.5%-2,241.1%-1,548.6%-813.2%-1,058.4%-543.0%-1,042.5%
Net income-5.8M-5.8M-5.4M-6.3M-5.4M-6.3M-6.7M-7.3M
Net margin-1,226.8%-3,022.8%-2,201.3%-1,545.2%-857.4%-1,402.8%-676.6%-1,837.7%
EPS————————

VolitionRX Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, VolitionRX’s quarterly revenue moved from $470,000 to $400,000. Net margin compressed from -1226.8% to -1837.7%, against a 100% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit.

When Is VolitionRX’s Next Earnings Date?

VolitionRX reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the VNRX earnings calendar.

Frequently Asked Questions: VolitionRX Earnings

VolitionRX's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

VolitionRX reported Q2 '26 revenue of $400,000, down 2.0% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the VNRX AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.